Improving Periodic Physicals in Women
-
Published:1968-07
Issue:1
Volume:44
Page:115-117
-
ISSN:0032-5481
-
Container-title:Postgraduate Medicine
-
language:en
-
Short-container-title:Postgraduate Medicine
Publisher
Informa UK Limited
Reference6 articles.
1. The pathology of the ovarian hormone
2. The association of vaginal bleeding to organic pathology and the endometrial pattern in the decades before the menopause
3. Hormonal Control of Functional Uterine Bleeding**The estrogen-progesterone-testosterone combinations used in our studies were supplied by the following pharmaceutical companies:Wyeth, Inc.: Tristerone (6 mg. estrone, 50 mg. progesterone, 25 mg. testosterone).Schering Corporation: Steratrin (1 mg. estradiol benzoate, 25 mg. progesterone, 25 mg. testoterone propionate).Sharp and Dohme, Inc.: Lukestra (1.66 mg. estradiol benzoate, 25 mg. progesterone, 25 mg. testosterone propionate).Ayerst, McKenna & Harrison Limited: Premarin Injectable, 20 mg. per vial of 5 c.c.
4. Experience with Mammography in a Tumor Institution